首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1378372

生物資訊學：各種技術與全球市場

Bioinformatics: Technologies and Global Markets

出版日期: 2023年11月07日 | 出版商:

BCC Research | 英文 481 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球生物資訊市場規模預計將從 2023 年的 187 億美元成長到年終的 355 億美元，預測期內年複合成長率為 13.6%。

基因組學應用的生物資訊市場規模預計將從 2023 年的 47 億美元成長到年終的90 億美元，年複合成長率為 14.1%。此外，蛋白質體學應用的生物資訊市場規模預計將從2023年的31億美元成長到年終的59億美元，複合年複合成長率為13.8%。

本報告調查了全球生物資訊學市場，提供了市場和技術概述、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析以及技術和專利趨勢。主要企業的發展、競爭形勢和概況。

生物資料來源
系統生物學中的生物資訊學
精準醫學中的生物資訊學
藥物開發中的生物資訊學
化學資訊學
次世代定序
宏基因體學中的生物資訊學
資料庫管理系統中的生物資訊學
市場趨勢
精準醫學和生物標記識別
雲端基礎的解決方案
過渡到基於價值的護理
ChatGPT 的崛起
市場挑戰
資料整合
資料可靠性和標準化
端到端工作流程
生物資訊工具和軟體市場趨勢
購買因素分析
實驗資料分析

第4章市場動態

概述
市場促進因素
市場抑制因素
市場機會

第5章市場區隔：依應用分類

概述
資訊超載
資料量
資料多樣性
資料速率
資料真實性
軟體的可擴展性和有效性
全球生物資訊市場：依應用分類
基因組學
蛋白質體學
轉錄組學
代謝組學
化學資訊學
藥物基因組學
宏基因體學
其他用途

第6章測序服務與平台市場

概述
全球定序服務與平台市場
定序服務
定序平台

第7章市場區隔：依解決方案

概述
全球生物資訊市場：按解決方案
服務
軟體
硬體及其細分市場

第8章市場細分：依最終用途

概述
全球生物資訊市場：依最終用途分類
研究
臨床/醫療
其他

第9章市場細分：依地區

概述
全球生物資訊市場：按地區
北美洲
歐洲
亞太地區
其他地區

第10章 ESG發展

ESG在生物資訊科技製造業的重要性
ESG 評級和指標：了解資料
生物資訊科技ESG在製造業的實踐
環保性能
社會表現
治理績效
案例分析
BCC 的觀點

第11章生物資訊學在藥物研發的應用

藥物研發/開發過程
目標識別
目標檢驗
線索識別
潛在客戶最佳化
臨床研究：藥物開發
臨床前實驗
新藥臨床實驗試驗申請
臨床試驗
新藥申請
新藥申請的核准
正在進行的上市後研究和 IV 期臨床試驗
電子病歷
行動健康技術
最近的製藥和生物資訊聯盟和合作夥伴關係
結論

第12章新技術和發展

生物資訊科技新趨勢
資料科學：科技新時代
軟計算方法
挑戰與未來的研究方向

第13章有關新軟體的定性資訊

FastFinder
WorkFlow Language
Seven Bridges Platform

第14章併購與資金籌措

併購分析
研究津貼
公共基金
私募基金

第15章競爭資訊

概述
世界企業排名分析

第16章公司簡介

3RD MILLENNIUM INC.
AITIA
AGILENT TECHNOLOGIES INC.
ARAGEN LIFE SCIENCES LTD.
BIOMATTERS LTD.（GENEIOUS）
BIO-RAD（ABD SEROTEC）
BIO-TECHNE
COMPUGEN LTD.
DASSAULT SYSTEMES BIOVIA
DNASTAR INC.
GENEDATA AG
GENEVA BIOINFORMATICS（GENEBIO）SA
ILLUMINA INC.
INTE：LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
MACVECTOR INC.
MOLECULAR CONNECTIONS PVT. LTD.
MOLECULAR NETWORKS GMBH
NONLINEAR DYNAMICS LTD.
OCIMUM BIOSOLUTIONS LTD.
PERKINELMER INFORMATICS INC.
PERSONALIS INC.
QLUCORE AB
REAL TIME GENOMICS INC.
SMARTGENE SERVICES SARL
SYNGENE INTERNATIONAL LTD.
THERMO FISHER SCIENTIFIC INC.

第17章附錄：縮寫

簡介目錄圖表

Product Code: BIO051G

Highlights:

The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.

The global market for bioinformatics in genomics applications is expected to grow from $4.7 billion in 2023 to $9.0 billion by the end of 2028, at a CAGR of 14.1% during the forecast period of 2023-2028.

The global market for bioinformatics in proteomics applications is expected to grow from $3.1 billion in 2023 to $5.9 billion by the end of 2028, at a CAGR of 13.8% during the forecast period of 2023-2028.

Report Scope:

The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.

By solution, hardware application, sequencing services and platform, end user, and geography, the market has been segmented into the North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. Detailed analysis of major countries such as the U.S., Germany, the UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and Australia will be covered in each country's respective regional segment. In the market valuations, 2022 serves as the base year, while estimated values are provided for 2023 and forecast values for 2028.

Report Includes:

123 data tables and 90 additional tables
An up-to-date overview and industry analysis of the global bioinformatics market
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimation of the market size and revenue forecast for the global bioinformatics market, and corresponding market share analysis based on solution, hardware type, application, sequencing services and platforms, end use, and region
In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
Coverage of information on the latest developments in the bioinformatics tools and services market, innovations in bioinformatics solutions for drug discovery, and details of antibody-based drug discovery and developments
Impact analysis of various region specific and industry specific macroeconomic variables on global bioinformatics market
Identification of the innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
Understanding of the importance of ESG in the market for bioinformatics tools and services, consumer attitudes towards sustainability, risks & opportunity assessment, ratings and matrices, and ESG practices in global bioinformatics marketplace
A look at the major vendors in the global bioinformatics market, and analyze the structure of this industry with respect to company market shares, venture fundings, and recent M&A activities
Patent analysis covering significant allotments of recent patent grants across each major category
Profile descriptions of the leading market players

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Methodology
Information Sources
Geographic Breakdown

Chapter 2 Summary and Highlights

Market Outlook
Market Summary

Chapter 3 Market Overview

Introduction
Biological Data Sources
Bioinformatics in Systems Biology
Bioinformatics in Precision Medicine
Bioinformatics in Drug Development
Cheminformatics
Next-Generation Sequencing
Bioinformatics in Metagenomics
Bioinformatics in Database Management Systems
Market Trends
Precision Medicine and Biomarker Identification
Cloud-Based Solutions
Shift Toward Value-Based Care
Rise of ChatGPT
Market Challenges
Data Integration
Data Reliability and Standardization
End-to-End Workflows
Market Trends in Bioinformatics Tools and Software
Purchasing Factors Analysis
Analyzing Experimental Data

Chapter 4 Market Dynamics

Overview
Market Drivers
New Discoveries in Biological Sciences
Increasing Use of Bioinformatics Analytical Software
New Antibody Technologies and Antibody Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
New Application-Focused Technology Platforms
Market Restraints
Challenging Issues with Modeling Systems
Ethical Concerns with Bioinformatics and Computational Genomics
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Bioinformatics and Drugs

Chapter 5 Market Breakdown by Application

Overview
Information Overload
Data Volume
Data Variety
Data Velocity
Data Veracity
Software Scalability and Validity
Global Market for Bioinformatics, by Application
Genomics
Proteomics
Transcriptomics
Metabolomics
Cheminformatics
Pharmacogenomics
Metagenomics
Other Applications

Chapter 6 Market for Sequencing Services and Platforms

Overview
Global Market for Sequencing Services and Platforms
Sequencing Services
Sequencing Platforms

Chapter 7 Market Breakdown by Solution

Overview
Global Market for Bioinformatics, by Solution
Services
Software
Hardware and Its Segments

Chapter 8 Market Breakdown by End Use

Overview
Global Market for Bioinformatics, by End Use
Research
Clinical and Medical
Other End Uses

Chapter 9 Market Breakdown by Region

Overview
Global Market for Bioinformatics, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 10 ESG Development

Importance of ESG in the Bioinformatics Technologies Manufacturing Industry
ESG Ratings and Metrics: Understanding the Data
ESG Practices in the Bioinformatics Technologies Manufacturing Industry
Environmental Performance
Social Performance
Governance Performance
Case Study
BCC Research Viewpoint

Chapter 11 Bioinformatics Applications in Pharmaceutical R&D

Introduction
Drug Discovery and Development Process
Target Identification
Target Validation
Lead Identification
Lead Optimization
Clinical Research: Drug Development
Preclinical Experiments
Investigational New Drug Applications
Clinical Trials
New Drug Application
NDA Approval
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Electronic Health Records
Mobile Health Technologies
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions

Chapter 12 Emerging Technologies and Developments

Introduction
Emerging Trends in Bioinformatics TechnologiesEmerging Trends in Bioinformatics Technologies
Data Science: The Era of New Technology
Soft Computing Approach
Challenges and Future Research Direction

Chapter 13 Qualitative Information on New Software

FastFinder
WorkFlow Language
Seven Bridges Platform

Chapter 14 M&A and Venture Funding Outlook

M&A Analysis
Research Grants
Public Funding
Private Funding

Chapter 15 Competitive Intelligence

Overview
Global Company Market Ranking Analysis

Chapter 16 Company Profiles

3RD MILLENNIUM INC.
AITIA
AGILENT TECHNOLOGIES INC.
ARAGEN LIFE SCIENCES LTD.
BIOMATTERS LTD. (GENEIOUS)
BIO-RAD (ABD SEROTEC)
BIO-TECHNE
COMPUGEN LTD.
DASSAULT SYSTEMES BIOVIA
DNASTAR INC.
GENEDATA AG
GENEVA BIOINFORMATICS (GENEBIO) SA
ILLUMINA INC.
INTE:LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
MACVECTOR INC.
MOLECULAR CONNECTIONS PVT. LTD.
MOLECULAR NETWORKS GMBH
NONLINEAR DYNAMICS LTD.
OCIMUM BIOSOLUTIONS LTD.
PERKINELMER INFORMATICS INC.
PERSONALIS INC.
QLUCORE AB
REAL TIME GENOMICS INC.
SMARTGENE SERVICES SARL
SYNGENE INTERNATIONAL LTD.
THERMO FISHER SCIENTIFIC INC.

Chapter 17 Appendix: Acronyms

簡介目錄圖表

List of Tables

Summary Table : Global Market for Bioinformatics, by Application, Through 2028
Table 1 : Recommendations for NGS Bioinformatics Tools
Table 2 : Bioinformatics Tools Used for Metagenomics Analysis
Table 3 : DBMS Platforms in Bioinformatics
Table 4 : Global Market for Bioinformatics, by Application, Through 2028
Table 5 : Cloud-Based Bioinformatics Tools
Table 6 : Global Market for Bioinformatics in Genomics Applications, by Region, Through 2028
Table 7 : Global Market for Bioinformatics in Proteomics Applications, by Region, Through 2028
Table 8 : Global Market for Bioinformatics in Transcriptomics Applications, by Region, Through 2028
Table 9 : Commercially Available Metabolomics Software
Table 10 : Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
Table 11 : Global Market for Bioinformatics in Metabolomics Applications, by Region, Through 2028
Table 12 : Cheminformatics Software Solutions for Drug R&D
Table 13 : Global Market for Bioinformatics in Cheminformatics Applications, by Region, Through 2028
Table 14 : Pharmacogenomic Biomarkers in Drug Labeling
Table 15 : Recent Research on Biomarkers, 2016-2023
Table 16 : Global Market for Bioinformatics in Pharmacogenomics Applications, by Region, Through 2028
Table 17 : Bioinformatics Tools and Databases Used in Pharmacogenomics
Table 18 : Bioinformatics Tools for Pharmacogenomic Studies
Table 19 : Tools for Metagenome Binning
Table 20 : Global Market for Bioinformatics in Metagenomics Applications, by Region, Through 2028
Table 21 : Planned or Ongoing Toxicogenomic Studies
Table 22 : Global Market for Bioinformatics in Other Applications, by Region, Through 2028
Table 23 : Global Market for Bioinformatics Sequencing Services and Platforms, by Segment, Through 2028
Table 24 : Global Market for Bioinformatics Sequencing Services, by Region, Through 2028
Table 25 : Sequence Analysis Software
Table 26 : Global Market for Bioinformatics Sequencing Platforms, by Region, Through 2028
Table 27 : Sequence Alignment Platforms
Table 28 : Global Market for Bioinformatics, by Solution, Through 2028
Table 29 : Global Market for Bioinformatics Hardware, by Type, Through 2028
Table 30 : Global Market for Bioinformatics Services, by Region, Through 2028
Table 31 : Bioinformatics Tools for Pharmacogenomic Software
Table 32 : Toxicogenomic Studies Planned or Ongoing
Table 33 : Archival Bioinformatics Databases
Table 34 : Curative Bioinformatics Databases
Table 35 : Commercially Available Bioinformatics Databases
Table 36 : Biological Databases for Human Research
Table 37 : Software for Biological Analysis
Table 38 : Open-Source Bioinformatics Software
Table 39 : NGS Platforms for Clinical Diagnostics
Table 40 : Commonly Used Tools for NGS-Based DNA Analysis, by Functional Category
Table 41 : Commercially Available Integrated DNA Analysis Solutions and Relevant Functionality
Table 42 : Global Market for Bioinformatics Software, by Region, Through 2028
Table 43 : High-Performance Computing Architectures: Advantages and Drawbacks
Table 44 : Highest Performance Supercomputers, 2018
Table 45 : SaaS Products
Table 46 : Global Market for Bioinformatics Hardware, by Region, Through 2028
Table 47 : Global Market for Bioinformatics Servers, by Region, Through 2028
Table 48 : Global Market for High-Performance Computing Clusters, by Region, Through 2028
Table 49 : Global Market for Storage Systems, by Region, Through 2028
Table 50 : Global Market for Bioinformatics Appliances, by Region, Through 2028
Table 51 : Global Market for Other Bioinformatics Hardware Types, by Region, Through 2028
Table 52 : Global Market for Bioinformatics, by End Use, Through 2028
Table 53 : Sequencing Data Analysis Bioinformatics Software and Tools
Table 54 : Global Market for Bioinformatics for Research End Uses, by Region, Through 2028
Table 55 : Global Market for Bioinformatics for Clinical and Medical End Uses, by Region, Through 2028
Table 56 : Bioinformatics-Based Clinical and Medical Laboratory Information Management System
Table 57 : Tools Used to Identify the Protein Structure in Bioinformatics for Healthcare Applications and Function
Table 58 : Number of Therapeutic Drugs Developed Globally, by Disease Type, 2022
Table 59 : Global Market for Other End Uses of Bioinformatics, by Region, Through 2028
Table 60 : Global Market for Bioinformatics, by Region, Through 2028
Table 61 : Number of Grants, by Type of Cancer, August 2023
Table 62 : North American Market for Bioinformatics, by Country, Through 2028
Table 63 : U.S. Market for Bioinformatics, by Solution, Through 2028
Table 64 : U.S. Market for Bioinformatics, by Hardware Type, Through 2028
Table 65 : U.S. Market for Sequencing Services and Platforms, Through 2028
Table 66 : U.S. Market for Bioinformatics, by Application, Through 2028
Table 67 : U.S. Market for Bioinformatics, by End Use, Through 2028
Table 68 : Leading Bioinformatics Companies in the U.S.
Table 69 : Venture Capital Companies Most Active in the Biotech Sector
Table 70 : Canadian Market for Bioinformatics, by Solution, Through 2028
Table 71 : Canadian Market for Bioinformatics, by Hardware Type, Through 2028
Table 72 : Canadian Market for Sequencing Services and Platforms, Through 2028
Table 73 : Canadian Market for Bioinformatics, by Application, Through 2028
Table 74 : Canadian Market for Bioinformatics, by End Use, Through 2028
Table 75 : Estimated New Male Cancer Cases in Canada, by Cancer Type, 2018
Table 76 : Estimated New Female Cancer Cases in Canada, by Cancer Type, 2018
Table 77 : Leading Canadian Bioinformatics Companies
Table 78 : Mexican Market for Bioinformatics, by Solution, Through 2028
Table 79 : Mexican Market for Bioinformatics, by Hardware Type, Through 2028
Table 80 : Mexican Market for Sequencing Services and Platforms, Through 2028
Table 81 : Mexican Market for Bioinformatics, by Application, Through 2028
Table 82 : Mexican Market for Bioinformatics, by End Use, Through 2028
Table 83 : European Market for Bioinformatics, by Country, Through 2028
Table 84 : Leading European Bioinformatics Companies
Table 85 : German Market for Bioinformatics, by Solution, Through 2028
Table 86 : German Market for Bioinformatics, by Hardware Type, Through 2028
Table 87 : German Market for Sequencing Services and Platforms, Through 2028
Table 88 : German Market for Bioinformatics, by Application, Through 2028
Table 89 : German Market for Bioinformatics, by End Use, Through 2028
Table 90 : French Market for Bioinformatics, by Solution, Through 2028
Table 91 : French Market for Bioinformatics, by Hardware Type, Through 2028
Table 92 : French Market for Sequencing Services and Platforms, Through 2028
Table 93 : French Market for Bioinformatics, by Application, Through 2028
Table 94 : French Market for Bioinformatics, by End Use, Through 2028
Table 95 : U.K. Market for Bioinformatics, by Solution, Through 2028
Table 96 : U.K. Market for Bioinformatics, by Hardware Type, Through 2028
Table 97 : U.K. Market for Sequencing Services and Platforms, Through 2028
Table 98 : U.K. Market for Bioinformatics, by Application, Through 2028
Table 99 : U.K. Market for Bioinformatics, by End Use, Through 2028
Table 100 : Italian Market for Bioinformatics, by Solution, Through 2028
Table 101 : Italian Market for Bioinformatics, by Hardware Type, Through 2028
Table 102 : Italian Market for Sequencing Services and Platforms, Through 2028
Table 103 : Italian Market for Bioinformatics, by Application, Through 2028
Table 104 : Italian Market for Bioinformatics, by End Use, Through 2028
Table 105 : Spanish Market for Bioinformatics, by Solution, Through 2028
Table 106 : Spanish Market for Bioinformatics, by Hardware Type, Through 2028
Table 107 : Spanish Market for Sequencing Services and Platforms, Through 2028
Table 108 : Spanish Market for Bioinformatics, by Application, Through 2028
Table 109 : Spanish Market for Bioinformatics, by End Use, Through 2028
Table 110 : Rest of European Market for Bioinformatics, by Solution, Through 2028
Table 111 : Rest of European Market for Bioinformatics, by Hardware Type, Through 2028
Table 112 : Rest of European Market for Sequencing Services and Platforms, Through 2028
Table 113 : Rest of European Market for Bioinformatics, by Application, Through 2028
Table 114 : Rest of European Market for Bioinformatics, by End Use, Through 2028
Table 115 : Asia-Pacific Market for Bioinformatics, by Country, Through 2028
Table 116 : Japanese Market for Bioinformatics, by Solution, Through 2028
Table 117 : Japanese Market for Bioinformatics, by Hardware Type, Through 2028
Table 118 : Japanese Market for Sequencing Services and Platforms, Through 2028
Table 119 : Japanese Market for Bioinformatics, by Application, Through 2028
Table 120 : Japanese Market for Bioinformatics, by End Use, Through 2028
Table 121 : Chinese Market for Bioinformatics, by Solution, Through 2028
Table 122 : Chinese Market for Bioinformatics, by Hardware Type, Through 2028
Table 123 : Chinese Market for Sequencing Services and Platforms, Through 2028
Table 124 : Chinese Market for Bioinformatics, by Application, Through 2028
Table 125 : Chinese Market for Bioinformatics, by End Use, Through 2028
Table 126 : Indian Market for Bioinformatics, by Solution, Through 2028
Table 127 : Indian Market for Bioinformatics, by Hardware Type, Through 2028
Table 128 : Indian Market for Sequencing Services and Platforms, Through 2028
Table 129 : Indian Market for Bioinformatics, by Application, Through 2028
Table 130 : Indian Market for Bioinformatics, by End Use, Through 2028
Table 131 : Leading Indian Bioinformatics Companies
Table 132 : Australian and New Zealand Market for Bioinformatics, by Solution, Through 2028
Table 133 : Australian and New Zealand Market for Bioinformatics, by Hardware Type, Through 2028
Table 134 : Australian and New Zealand Market for Sequencing Services and Platforms, Through 2028
Table 135 : Australian and New Zealand Market for Bioinformatics, by Application, Through 2028
Table 136 : Australian and New Zealand Market for Bioinformatics, by End Use, Through 2028
Table 137 : Rest of Asia-Pacific Market for Bioinformatics, by Solution, Through 2028
Table 138 : Rest of Asia-Pacific Market for Bioinformatics, by Hardware Type, Through 2028
Table 139 : Rest of Asia-Pacific Market for Sequencing Services and Platforms, Through 2028
Table 140 : Rest of Asia-Pacific Market for Bioinformatics, by Application, Through 2028
Table 141 : Rest of Asia-Pacific Market for Bioinformatics, by End Use, Through 2028
Table 142 : Rest of the World Market for Bioinformatics, by Country, Through 2028
Table 143 : Brazilian Market for Bioinformatics, by Solution, Through 2028
Table 144 : Brazilian Market for Bioinformatics, by Hardware Type, Through 2028
Table 145 : Brazilian Market for Sequencing Services and Platforms, Through 2028
Table 146 : Brazilian Market for Bioinformatics, by Application, Through 2028
Table 147 : Brazilian Market for Bioinformatics, by End Use, Through 2028
Table 148 : GCC Countries Market for Bioinformatics, by Solution, Through 2028
Table 149 : GCC Countries Market for Bioinformatics, by Hardware Type, Through 2028
Table 150 : GCC Countries Market for Sequencing Services and Platforms, Through 2028
Table 151 : GCC Countries Market for Bioinformatics, by Application, Through 2028
Table 152 : GCC Countries Market for Bioinformatics, by End Use, Through 2028
Table 153 : Other Rest of the World Countries Market for Bioinformatics, by Solution, Through 2028
Table 154 : Other Rest of the World Countries Market for Bioinformatics, by Hardware Type, Through 2028
Table 155 : Other Rest of the World Countries Market for Sequencing Services and Platforms, Through 2028
Table 156 : Other Rest of the World Countries Market for Bioinformatics, by Application, Through 2028
Table 157 : Other Rest of the World Countries Market for Bioinformatics, by End Use, Through 2028
Table 158 : R&D Spending on Bioinformatics by Latin American Countries
Table 159 : ESG Ratings and Metrics: Understanding the Data
Table 160 : ESG Practices in the Bioinformatics Technologies
Table 161 : ESG Social Performance
Table 162 : ESG Governance Performance
Table 163 : Recently Received Awards by Major Companies
Table 164 : ESG Rankings for Major Bioinformatics Technologies Companies, 2023*
Table 165 : Bioinformatics Databases
Table 166 : Leading Drug Target Databases
Table 167 : Computer Simulation Platforms
Table 168 : Application of Cloud-Based Services in Healthcare
Table 169 : Leading LIMS Providers
Table 170 : Key Suppliers of ELNs
Table 171 : Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
Table 172 : Drug R&D Process Overview
Table 173 : Leading EHR Providers, 2018
Table 174 : Medical Applications for Healthcare Professionals
Table 175 : Pharmaceutical and Bioinformatics Partnerships and Alliances, 2015-2020
Table 176 : Emerging Trends of Bioinformatics Technologies
Table 177 : Prominent Data Analysis Toolkits for Solving Problem of Data Science
Table 178 : Recent Strategic Developments in the Bioinformatics Market, 2019-2023
Table 179 : Public Funding Programs, 2012-2018
Table 180 : Funding by European Bioinformatics Firms, 2021 and 2022
Table 181 : Aitia: Product Portfolio
Table 182 : Aitia: Recent Developments, 2015-2023
Table 183 : Agilent Technologies Inc.: Product Portfolio
Table 184 : Aragen Life Sciences Ltd.: Product Portfolio
Table 185 : Biomatters Ltd.: Product Portfolio
Table 186 : Bio-Rad: Product Portfolio
Table 187 : Bio-Techne: Product Portfolio
Table 188 : Compugen Ltd.: Product Portfolio
Table 189 : Dassault Systemes Biovia: Product Portfolio
Table 190 : DNAStar Inc.: Product Portfolio
Table 191 : DNAStar Inc.: Recent Developments, 2016-2022
Table 192 : Genedata AG: Product Portfolio
Table 193 : Genedata AG: Recent Developments, 2017-2023
Table 194 : Geneva Informatics (GeneBio) SA: Product Portfolio
Table 195 : Illumina Inc.: Product Portfolio
Table 196 : Inte:Ligand Software Entwicklungs Und Consulting GmbH: Product Portfolio
Table 197 : MacVector Inc.: Product Portfolio
Table 198 : Molecular Connections Pvt. Ltd.: Product Portfolio
Table 199 : Molecular Networks GmbH: Product Portfolio
Table 200 : Nonlinear Dynamics Ltd.: Product Portfolio
Table 201 : Ocimum Biosolutions Ltd.: Product Portfolio
Table 202 : PerkinElmer Informatics Inc.: Product Portfolio
Table 203 : Personalis Inc.: Product Portfolio
Table 204 : Qlucore AB: Product Portfolio
Table 205 : Qlucore AB: Recent Developments, 2018
Table 206 : Real Time Genomics Inc.: Product Portfolio
Table 207 : Real Time Genomics Inc.: Recent Developments, 2016
Table 208 : SmartGene Services SARL: Product Portfolio
Table 209 : Syngene International Ltd.: Product Portfolio
Table 210 : Syngene International Ltd.: Recent Developments, 2016-2023
Table 211 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 212 : Acronyms Used in This Report

List of Figures

Summary Figure : Global Market Shares of Bioinformatics, by Application, 2022
Figure 1 : Bioinformatics Relationship with Omic Technologies
Figure 2 : Schematic Representation of Biology Systems and Translational Bioinformatics
Figure 3 : Principles of Precision Medicine
Figure 4 : Recent FDA-Approved Cell-Based Therapies
Figure 5 : Applications of Bioinformatics in Drug Development
Figure 6 : Collaboration within the Bioinformatics Sector, by Country, Since 2016
Figure 7 : Number of FDA CDER Drug Approvals, 2008-2020
Figure 8 : Drug Product Approvals in Europe and the U.S., 2020
Figure 9 : CDER's Annual Novel Drug Approvals, 2009-2019
Figure 10 : Investment by Genome Canada, Since 2000
Figure 11 : Major Socioeconomic and Political Factors Negatively Influencing the Bioinformatics Market
Figure 12 : The Four Dimensions of Big Data
Figure 13 : Software Scalability of Big Data Bioinformatics
Figure 14 : Software Validation of Big Data Bioinformatics
Figure 15 : Global Market Shares of Bioinformatics, by Application, 2022
Figure 16 : Global Market Shares of Bioinformatics, by Application, 2028
Figure 17 : Standard Antibody Sequencing Service Process
Figure 18 : Global Market for Bioinformatics in Genomics Applications, 2020-2028
Figure 19 : Global Market for Bioinformatics in Genomics Applications, by Region, 2020-2028
Figure 20 : Distribution of Cancer Incidence, by Cancer Type, 2020
Figure 21 : Top-Down Proteomics Approach
Figure 22 : Global Demand for EMBL-EBI Data, 2018-2022
Figure 23 : Global Market for Bioinformatics in Proteomics Applications, 2020-2028
Figure 24 : Global Market for Bioinformatics in Proteomics Applications, by Region, 2020-2028
Figure 25 : Global Market for Bioinformatics in Transcriptomics Applications, 2020-2028
Figure 26 : Global Market for Bioinformatics in Transcriptomics Applications, by Region, 2020-2028
Figure 27 : Global Market for Bioinformatics in Metabolomics Applications, 2020-2028
Figure 28 : Global Market for Bioinformatics in Metabolomics Applications, by Region, 2020-2028
Figure 29 : Global Market for Bioinformatics in Cheminformatics Applications, 2020-2028
Figure 30 : Global Market for Bioinformatics in Cheminformatics Applications, by Region, 2020-2028
Figure 31 : Global Market for Bioinformatics in Pharmacogenomics Applications, 2020-2028
Figure 32 : Global Market for Bioinformatics in Pharmacogenomics Applications, by Region, 2020-2028
Figure 33 : Global Market for Bioinformatics in Metagenomics Applications, 2020-2028
Figure 34 : Global Market for Bioinformatics in Metagenomics Applications, by Region, 2020-2028
Figure 35 : Global Market for Bioinformatics in Other Applications, 2020-2028
Figure 36 : Global Market for Bioinformatics in Other Applications, by Region, 2020-2028
Figure 37 : Global Market Shares of Bioinformatics Sequencing Services and Platforms, by Segment, 2022
Figure 38 : Global Market Shares of Bioinformatics Sequencing Services and Platforms, by Segment, 2028
Figure 39 : Global Market for Bioinformatics Sequencing Services, 2020-2028
Figure 40 : Global Market for Bioinformatics Sequencing Services, by Region, 2020-2028
Figure 41 : Global Market for Bioinformatics Sequencing Platforms, 2020-2028
Figure 42 : Global Market for Bioinformatics Sequencing Platforms, by Region, 2020-2028
Figure 43 : Global Market Shares of Bioinformatics, by Solution, 2022
Figure 44 : Global Market Shares of Bioinformatics, by Solution, 2028
Figure 45 : Global Market Shares of Bioinformatics Hardware, by Type, 2022
Figure 46 : Global Market Shares of Bioinformatics Hardware, by Type, 2028
Figure 47 : Global Market for Bioinformatics Services, 2020-2028
Figure 48 : Global Market for Bioinformatics Tools and Database Services, by Region, 2020-2028
Figure 49 : European Bioinformatics Institute Software Solutions
Figure 50 : Global Market for Bioinformatics Software, 2020-2028
Figure 51 : Global Market for Bioinformatics Software, by Region 2020-2028
Figure 52 : Evolution of Information Technology Infrastructure
Figure 53 : Schematic Representation of Cloud Computing Services
Figure 54 : Global Market for Bioinformatics Hardware, 2020-2028
Figure 55 : Global Market for Bioinformatics Hardware, by Region, 2020-2028
Figure 56 : Global Market Shares of Bioinformatics, by End Use, 2022
Figure 57 : Global Market Shares of Bioinformatics, by End Use, 2028
Figure 58 : Global Incidence of Patients with Chronic Diseases, 2005-2030
Figure 59 : Global Market for Bioinformatics for Research End Uses, 2020-2028
Figure 60 : Global Market for Bioinformatics for Research End Uses, by Region, 2020-2028
Figure 61 : Global Market for Bioinformatics for Clinical and Medical End Uses, 2020-2028
Figure 62 : Global Market for Bioinformatics for Clinical and Medical End Uses, by Region, 2020-2028
Figure 63 : Clinical Bioinformatics for Patients for Precision Health
Figure 64 : Estimate of Biopharmaceutical R&D Spending, 2012-2026
Figure 65 : Number of Therapeutic Drugs Developed Globally, by Disease Type, 2022
Figure 66 : Global Market for Other End Uses of Bioinformatics, 2020-2028
Figure 67 : Global Market for Other End Uses of Bioinformatics, by Region, 2020-2028
Figure 68 : Classical and Digital Forensics with Respect to Bioinformatics
Figure 69 : Global Market Shares of Bioinformatics, by Region, 2022
Figure 70 : Global Market Shares of Bioinformatics, by Region, 2028
Figure 71 : North American Market Shares of Bioinformatics, by Solution, 2022
Figure 72 : North American Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 73 : North American Market Shares of Sequencing Services and Platforms, 2022
Figure 74 : North American Market Shares of Bioinformatics, by Application, 2022
Figure 75 : North American Market Shares of Bioinformatics, by End Use, 2022
Figure 76 : North American Market Shares of Bioinformatics, by Country, 2022
Figure 77 : U.S. Market for Bioinformatics, 2020-2028
Figure 78 : U.S. Market Shares of Bioinformatics, by Solution, 2022
Figure 79 : U.S. Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 80 : U.S. Market Shares of Sequencing Services and Platforms, 2022
Figure 81 : U.S. Market Shares of Bioinformatics, by Application, 2022
Figure 82 : U.S. Market Shares of Bioinformatics, by End Use, 2022
Figure 83 : Canadian Market for Bioinformatics, 2020-2028
Figure 84 : Canadian Market Shares of Bioinformatics, by Solution, 2022
Figure 85 : Canadian Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 86 : Canadian Market Shares of Bioinformatics Sequencing Services and Platforms, 2022
Figure 87 : Canadian Market Shares of Bioinformatics, by Application, 2022
Figure 88 : Canadian Market Shares of Bioinformatics, by End Use, 2022
Figure 89 : Mexican Market for Bioinformatics, 2020-2028
Figure 90 : Mexican Market Shares of Bioinformatics, by Solution, 2022
Figure 91 : Mexican Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 92 : Mexican Market Shares of Sequencing Services and Platforms, 2022
Figure 93 : Mexican Market Shares of Bioinformatics, by Application, 2022
Figure 94 : Mexican Market Shares of Bioinformatics, by End Use, 2022
Figure 95 : European Market Shares of Bioinformatics, by Solution, 2022
Figure 96 : European Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 97 : European Market Shares of Sequencing Services and Platforms, 2022
Figure 98 : European Market Shares of Bioinformatics, by Application, 2022
Figure 99 : European Market Shares of Bioinformatics, by End Use, 2022
Figure 100 : European Market Shares of Bioinformatics, by Country, 2022
Figure 101 : German Market for Bioinformatics, 2020-2028
Figure 102 : German Market Shares of Bioinformatics, by Solution, 2022
Figure 103 : German Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 104 : German Market Shares of Sequencing Services and Platforms, 2022
Figure 105 : German Market Shares of Bioinformatics, by Application, 2022
Figure 106 : German Market Shares of Bioinformatics, by End Use, 2022
Figure 107 : Current Molecular-Experimental, Epidemiological and Analytical Tools Applied in Systems Medicine
Figure 108 : French Market for Bioinformatics, 2020-2028
Figure 109 : French Market Shares of Bioinformatics, by Solution, 2022
Figure 110 : French Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 111 : French Market Shares of Sequencing Services and Platforms, 2022
Figure 112 : French Market Shares of Bioinformatics, by Application, 2022
Figure 113 : French Market Shares of Bioinformatics, by End Use, 2022
Figure 114 : Healthcare Spending and Financing in France, 2019 and 2050
Figure 115 : U.K. Market for Bioinformatics, 2020-2028
Figure 116 : U.K. Market Shares of Bioinformatics, by Solution, 2022
Figure 117 : U.K. Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 118 : U.K. Market Shares of Sequencing Services and Platforms, 2022
Figure 119 : U.K. Market Shares of Bioinformatics, by Application, 2022
Figure 120 : U.K. Market Shares of Bioinformatics, by End Use, 2022
Figure 121 : Italian Market for Bioinformatics, 2020-2028
Figure 122 : Italian Market Shares of Bioinformatics, by Solution, 2022
Figure 123 : Italian Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 124 : Italian Market Shares of Sequencing Services and Platforms, 2022
Figure 125 : Italian Market Shares of Bioinformatics, by Application, 2022
Figure 126 : Italian Market Shares of Bioinformatics, by End Use, 2022
Figure 127 : Spanish Market for Bioinformatics, 2020-2028
Figure 128 : Spanish Market Shares of Bioinformatics, by Solution, 2022
Figure 129 : Spanish Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 130 : Spanish Market Shares of Sequencing Services and Platforms, 2022
Figure 131 : Spanish Market Shares of Bioinformatics, by Application, 2022
Figure 132 : Spanish Market Shares of Bioinformatics, by End Use, 2022
Figure 133 : Rest of European Market for Bioinformatics, 2020-2028
Figure 134 : Rest of European Market Shares of Bioinformatics, by Solution, 2022
Figure 135 : Rest of European Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 136 : Rest of European Market Shares of Sequencing Services and Platforms, 2022
Figure 137 : Rest of European Market Shares of Bioinformatics, by Application, 2022
Figure 138 : Rest of European Market Shares of Bioinformatics, by End Use, 2022
Figure 139 : Asia-Pacific Market Shares of Bioinformatics, by Solution, 2022
Figure 140 : Asia-Pacific Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 141 : Asia-Pacific Market Shares of Sequencing Services and Platforms, 2022
Figure 142 : Asia-Pacific Market Shares of Bioinformatics, by Application, 2022
Figure 143 : Asia-Pacific Market Shares of Bioinformatics, by End Use, 2022
Figure 144 : Asia-Pacific Market Shares of Bioinformatics, by Country, 2022
Figure 145 : Japanese Market for Bioinformatics, 2020-2028
Figure 146 : Japanese Market Shares of Bioinformatics, by Solution, 2022
Figure 147 : Japanese Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 148 : Japanese Market Shares of Sequencing Services and Platforms, 2022
Figure 149 : Japanese Market Shares of Bioinformatics, by Application, 2022
Figure 150 : Japanese Market Shares of Bioinformatics, by End Use, 2022
Figure 151 : Chinese Market for Bioinformatics, 2020-2028
Figure 152 : Chinese Market Shares of Bioinformatics, by Solution, 2022
Figure 153 : Chinese Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 154 : Chinese Market Shares of Sequencing Services and Platforms, 2022
Figure 155 : Chinese Market Shares of Bioinformatics, by Application, 2022
Figure 156 : Chinese Market Shares of Bioinformatics, by End Use, 2022
Figure 157 : Indian Market for Bioinformatics, 2020-2028
Figure 158 : Indian Market Shares of Bioinformatics, by Solution, 2022
Figure 159 : Indian Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 160 : Indian Market Shares of Sequencing Services and Platforms, 2022
Figure 161 : Indian Market Shares of Bioinformatics, by Application, 2022
Figure 162 : Indian Market Shares of Bioinformatics, by End Use, 2022
Figure 163 : Key Areas of Research Utilizing Bioinformatics
Figure 164 : Australian and New Zealand Market for Bioinformatics, 2020-2028
Figure 165 : Australian and New Zealand Market Shares of Bioinformatics, by Solution, 2022
Figure 166 : Australian and New Zealand Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 167 : Australian and New Zealand Market Shares of Sequencing Services and Platforms, 2022
Figure 168 : Australian and New Zealand Market Shares of Bioinformatics, by Application, 2022
Figure 169 : Australian and New Zealand Market Shares of Bioinformatics, by End Use, 2022
Figure 170 : Rest of Asia-Pacific Market for Bioinformatics, 2020-2028
Figure 171 : Rest of Asia-Pacific Market Shares of Bioinformatics, by Solution, 2022
Figure 172 : Rest of Asia-Pacific Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 173 : Rest of Asia-Pacific Market Shares of Sequencing Services and Platforms, 2022
Figure 174 : Rest of Asia-Pacific Market Shares of Bioinformatics, by Application, 2022
Figure 175 : Rest of Asia-Pacific Market Shares of Bioinformatics, by End Use, 2022
Figure 176 : Rest of the World Market Shares of Bioinformatics, by Solution, 2022
Figure 177 : Rest of the World Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 178 : Rest of the World Market Shares of Sequencing Services and Platforms, 2022
Figure 179 : Rest of the World Market Shares of Bioinformatics, by Application, 2022
Figure 180 : Rest of the World Market Shares of Bioinformatics, by End Use, 2022
Figure 181 : Rest of the World Market Shares of Bioinformatics, by Country, 2019
Figure 182 : Brazilian Market for Bioinformatics, 2020-2028
Figure 183 : Brazilian Market Shares of Bioinformatics, by Solution, 2022
Figure 184 : Brazilian Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 185 : Brazilian Market Shares of Sequencing Services and Platforms, 2022
Figure 186 : Brazilian Market Shares of Sequencing Services and Platforms, 2022
Figure 187 : Brazilian Market Shares of Bioinformatics, by End Use, 2022
Figure 188 : GCC Countries Market for Bioinformatics, 2020-2028
Figure 189 : GCC Countries Market Shares of Bioinformatics, by Solution, 2022
Figure 190 : GCC Countries Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 191 : GCC Countries Market Shares of Sequencing Services and Platforms, 2022
Figure 192 : GCC Countries Market Shares of Bioinformatics, by Application, 2022
Figure 193 : GCC Countries Market Shares of Bioinformatics, by End Use, 2022
Figure 194 : Other Rest of the World Countries Market for Bioinformatics, 2020-2028
Figure 195 : Other Rest of the World Countries Market Shares of Bioinformatics, by Solution, 2022
Figure 196 : Other Rest of the World Countries Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 197 : Other Rest of the World Countries Market Shares of Sequencing Services and Platforms, 2022
Figure 198 : Other Rest of the World Countries Market Shares of Bioinformatics, by Application, 2022
Figure 199 : Other Rest of the World Countries Market Shares of Bioinformatics, by End Use, 2022
Figure 200 : Number of Research Articles Published by Scientists from 19 Latin American Countries on Bioinformatics and Computational Biology, 1991-2016
Figure 201 : Policy, Infrastructure, Training and Funding Landscape of Computational Biology in South Africa, 2000-Present
Figure 202 : Snapshot of Key ESG Trends in the Bioinformatics Technologies Industry
Figure 203 : PerkinElmer Informatics Inc.: ESG Priorities Matrix
Figure 204 : Bio-Rad Laboratories Inc.: ESG Priorities Matrix
Figure 205 : Drug Development Process
Figure 206 : Phases in the Drug Discovery and Development Process
Figure 207 : Phase Transition Success Rates and Likelihood of Approvals for All Modalities and Medicines
Figure 208 : Steps in Drug Discovery
Figure 209 : Information Systems within the Laboratory Architecture
Figure 210 : Application of Bioinformatics in Clinical Trials
Figure 211 : Snapshot of Key Trends in the Growth of Diabetes Medical Devices
Figure 212 : Snapshot of Key Trends in the Growth of Bioinformatics Technologies
Figure 213 : Classification of Soft Computing Approach
Figure 214 : Investment by Genome Canada, Since 2000
Figure 215 : Global Market Ranking of Bioinformatics Manufacturers, 2019
Figure 216 : Agilent Technologies Inc.: Annual Revenue, 2016-2022
Figure 217 : Agilent Technologies Inc.: Revenue Share, by Region/Country, 2022
Figure 218 : Agilent Technologies Inc.: Revenue Share, by Business Segment, 2022
Figure 219 : Aragen Life Sciences Ltd.: Annual Revenue, 2021 and 2022
Figure 220 : Bio-Rad: Annual Revenue, 2016-2022
Figure 221 : Bio-Rad: Revenue Share, by Region, 2022
Figure 222 : Bio-Rad: Revenue Share, by Business Unit, 2022
Figure 223 : Bio-Techne: Annual Revenue, 2016-2022
Figure 224 : Bio-Techne: Revenue Share, by Region/Country, 2022
Figure 225 : Bio-Techne: Revenue Share, by Business Segment, 2022
Figure 226 : Illumina Inc.: Annual Revenue, 2018-2022
Figure 227 : Illumina Inc.: Revenue Share, by Region/Country, 2022
Figure 228 : Illumina Inc.: Revenue Share, by Business Segment, 2022
Figure 229 : PerkinElmer Informatics Inc: Revenue Share, by Region/Country, 2022
Figure 230 : Personalis Inc.: Revenue Share, by Region/Country, 2022
Figure 231 : Syngene International Ltd.: Annual Revenue, 2021-2022
Figure 232 : Syngene International Ltd.: Revenue Share, by Region/Country, 2022
Figure 233 : Thermo Fisher Scientific Inc.: Annual Revenue, 2016-2022
Figure 234 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022
Figure 235 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2022